Using electromagnetic fields during sleep to help manage type 2 diabetes
Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
This project is developing a new 'sleep to treat' device that uses gentle electromagnetic fields to help people with type 2 diabetes better control their blood sugar.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Geminii, INC. NIH-funded |
| Lab location | 1 site (iowa city, UNITED STATES) |
| Project ID | NIH-11006975 on NIH RePORTER |
What this research studies
Many people with type 2 diabetes find it hard to stick to their medication plans, often due to complex regimens or discomfort, which can lead to serious health issues. This innovative project aims to create a non-invasive solution called NeuWave, which delivers unique magnetic and electric fields while you sleep. The technology works by gently adjusting your body's metabolism to improve how your cells use sugar and increase your sensitivity to insulin. This approach seeks to offer a simple, automated way to manage type 2 diabetes without the need for daily medications.
Who could benefit from this research
Good fit: This research is ultimately for adults living with type 2 diabetes who struggle with medication adherence or are seeking alternative treatment options.
Not a fit: Patients whose type 2 diabetes is well-controlled with current medications or who do not have type 2 diabetes would likely not benefit from this specific approach.
Why it matters
Potential benefit: If successful, this technology could offer a simple, non-invasive way to manage type 2 diabetes without daily medications, potentially improving adherence and health outcomes.
How similar studies have performed: While bioelectronic medicine is an emerging field, this specific 'sleep to treat' approach targeting insulin resistance with non-invasive electromagnetic fields appears to be a novel development.
Where this research is happening
iowa city, UNITED STATES
- Geminii, INC. — iowa city, United States (Active)
Researchers
- Principal investigator: Carter, Calvin — Geminii, INC.
- Study coordinator: Carter, Calvin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.